A new study now online in the medical journal Neurology found that women are underrepresented in stroke clinical trials relative to the number who have strokes in the general population. […]
Biomedical workforce diversity is critical to advancing clinical trial participation among underserved populations and improving the scientific quality of data for everyone, the U.S. National Institutes of Health’s (NIH’s) Dr. […]
An understanding of human nature suggests that in a post-COVID-19 era for clinical trials, the pendulum may temporarily swing away from the increased adoption of decentralized clinical trials (DCTs) and […]
Looking for more evidence that decentralized clinical trials are for real? Check out the new “Digital Clinical Trials Survey Report” from Veeva, which found that adoption of decentralized technologies […]
As it enthusiastically embraces aspects of decentralized clinical trials (DCTs), the drug and device development industry is running the risk of “leapfrogging over [study] sites and forgetting about them as a key stakeholder” in the enterprise, says Mary Costello, Head of the Site and Investigator Network, Medable.